Federal award (DEFINITIVE CONTRACT, fiscal year 2022)
Recipient: UNIVERSITY OF BIRMINGHAM
Awarding agency: Department of Health and Human Services / Food and Drug Administration
Funding agency: Department of Health and Human Services / Food and Drug Administration
Period of performance: 2018-09-14 to 2021-09-30
Current total value of award: $237438.21
Description: DEOB AND CLOSEOUT MODIFICATION - BAA BETTER UNDERSTANDING RISK MITIGATION IN THE EVALUATION OF RELATIVE BIOAVAILABILITY OF PEDIATRIC GENERIC PRODUCTS